Frazier's Keytruda-shaped legacy at Merck
FirstTake on Pharma - Pharma News and Analysis Podcast
English - February 08, 2021 23:00 - 29 minutes - 22.2 MB - ★★★★★ - 2 ratingsScience pharma pharmaceutical intelligence firstword firsttake cardiovascular dermatology diabetes immunology infectious diseases Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Next Episode: Oral Inflammatory Drugs At Key Inflection Points
FirstWord Pharma PLUS editors Michael Flanagan and Simon King discuss the week’s most important news in pharma and biotech including Pfizer’s revenue expectations for its COVID-19 vaccine, the announcement that Ken Frazier will step down as CEO at Merck & Co. and why approval of aducanumab is so critical for Biogen.